Pharmaceutical

Eleven and Novo Nordisk partner to develop nucleic acid therapeutics

The companies will develop new molecules using Eleven's innovative DELiveri platform to treat cardiometabolic diseases.

Jul 17, 2023 - 20:00
Eleven and Novo Nordisk partner to develop nucleic acid therapeutics
The companies will develop new molecules using Eleven's innovative DELiveri platform to treat cardiometabolic diseases.
Read the original article

Tags:

Previous Article

FDA expands Veklury’s use to Covid-19 patients with severe kidney disease

Next Article

SNIPR celebrates US court’s favourable ruling on CRISPR patent

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes

After ‘SNL’ skit on sickle cell CRISPR therapy, advocat...

Dec 21, 2023

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihoo...

Feb 20, 2024

STAT+: ADA says all diabetes patients should be screened for nonalcoholic fatty liver disease

STAT+: ADA says all diabetes patients should be screene...

Jun 26, 2023